Publications

Lee SY, Joung KI, Kim KJ*, An SH*. Differential Effects of Wearable Device–based Interventions on Weight and Health Outcomes in Adults and Youth with Overweight or Obesity: A Systematic Review and Meta-analysis. Digital Health, 2026;12:1-15. (SSCI, SCIE, IF 3.3, JCR Top 11.6%) - Co-corresponding author

Peng M, Shen P, Kim KJ*. Effects of Continuous Glucose Monitoring on Physical Activity and Diet in Diabetes: A Systematic Review and Meta-analysis . International Journal of Behavioral Nutrition and Physical Activity (IJBNPA), 2026;23:14. (SCIE, IF 5.5, JCR Top 6.3%) - Corresponding author  

Peng M, Shen P, Joung KI, Kim KJ*. Safety profile of metformin in adolescents with type 2 diabetes: A pharmacovigilance analysis of the FDA adverse event reporting system. PLOS One, 2025;20(11):e0337204. (SCIE, IF 2.6, Q2) - Corresponding author 

Kim JH, Bang JS, Kim KJ*. The Effects of Large-scale Infections on the Use of Prescription Medicati on in the Community: Focusing on Novel Swine-Origin Influenza and Middle East Respiratory Syndrome. Yakhak Hoeji, 2025;69(2):116-124. (KCI) - Corresponding author

Joung KI, An SH, Bang JS, Kim KJ*. Comparative Effectiveness of Wearable Devices and Built-In Step Counters in Reducing Metabolic Syndrome Risk in South Korea: Population-Based Cohort Study. JMIR mHealth and uHealth, 2025;13:e64527. (SCIE, IF 6.2, JCR Top 5.1%) - Corresponding author                                                                                                                                                                                                                        

Cho K, Jeong EJ, Jeong SH, Kim KT, Kim KJ*, Kim NA*. Causes and Analytical Methods for Subvisible Particles Formed in Post-Marketing Biopharmaceutical Products. Yakhak Hoeji, 2024;68(6):399-408. (KCI) - Co-corresponding author

Yu GU, Kim HA, Chung EK, Rhie SJ*, Kim KJ*. Characteristics of E-sports and the Role of Pharmacist in Doping. Korean J Clin Pharm, 2024;34(4):203-209. (KCI) - Co-corresponding author

Hada S, Shin IJ, Park HE, Kim KH, Kim KJ, Jeong SH*, Kim NA*. In-use stability of Rituximab and IVIG during intravenous infusion: Impact of peristaltic pump, IV bags, flow rate, and plastic syringes. International Journal of Pharmaceutics, 2024;663:124577. (SCIE, IF 5.3, JCR Top 9.7% ) - Co-author

Kim DJ, Lee YS, Jeon ER, Kim KJ*. Present and Future of AI-IoT-Based Healthcare Services for Senior Citizens in Local Communities: A Review of a South Korean Government Digital Healthcare Initiatives. Healthcare, 2024;12(2):281. (SCIE, IF 2.7, Q2 ) - Co-corresponding author

Jeong YR, Park EY, Baek DJ, Bang JS*, Kim KJ*. Characteristics and User Evaluation of Digital Therapeutics: An Exploratory Study Focusing on reSET®, reSET-O®, and Somryst®. Yakhak Hoeji, 2023;67(5):285-293. (KCI) - Co-corresponding author

Cho K, Kim KJ*. Investigation of International Status on Digital Health Policies in the Health Care Sector. Yakhak Hoeji, 2023;67(2):85-93. (KCI) - Corresponding author

Choi JM, Kim KJ*. Characteristics of Digital Therapeutics and the Role of Pharmacist. Yakhak Hoeji, 2023;67(2): 67-74. (KCI) - Corresponding author

Kim KJ*. New goals and new opportunities for better nutrition care in hospitals. Annals of Clinical Nutrition and Metabolism, 2023:15(2).39. - Corresponding author (Editorial)

Kim JE, Park TS, Kim KJ*. The clinical effects of type 2 diabetes patient management using digital healthcare technology: a systematic review and meta-analysis. Healthcare, 2022;10(3):522. (SCIE, IF 2.8, Q2) - Corresponding author

Song B, Kim KJ*, Ki SH*. Experience with and perceptions of non-prescription anthelmintics for cancer treatments among cancer patients in South Korea: A cross-sectional survey. PLOS One, 2022;17(10):e0275620. (SCIE, IF 3.7, Q2) - Co-corresponding author

Song B, Park EY, Kim KJ*, Ki SH*. Repurposing of benzimidazole anthelmintic drugs as cancer therapeutics. Cancers, 2022;4(19):4601. (SCIE, IF 5.2, Q2) - Co-corresponding author

Kim SB, Kim KJ, Shrestha J, Oh YS, Lee JY, Lee S, Park EY*, Baek DJ*. Synthesis and Cytotoxic Activity of Fingolimod (FTY720) Analogs with Various Amide Head Group. Pharmaceutical Chemistry Journal, 2022;56 (4): 439-445. (SCIE) - Co-author

Kim SB, Oh YS, Kim KJ, Cho SW, Park SK, Baek DJ*, Park EY*. Synthesis of PP2A-Activating PF-543 derivatives and investigation of their inhibitory effects on pancreatic cancer cells. Molecules, 2022;27 (10): 3346. (SCIE, IF 4.6, Q2) - Co-author

Kim KJ*. Digital Healthcre in Community Pharmacy. Korean Journal of Community Pharmacy, 2022;8(11): 20-23. - Corresponding author 

Hwang J, Lee M, Seo Y, Kim KJ*. Analysis of Unused and Expired Medication Collected through Home Pharmaceutical Care Service. Yakhak Hoeji, 2021;65(6):413-423. (KCI) - Corresponding author

Hong JH, Kim KJ*. Investigation of International Status of Sports Pharmacy Guideline. Yakhak Hoeji, 2021;65(6:):460-465. (KCI) - Corresponding author

Yang IK, Shin EO, Kim DG, Jung HC, Kim KJ*, Ki SH*. Pharmacy services for the 2019 Fédération Internationale de Natation (FINA) World Masters Championships in Gwangju, South Korea. BMC Sports Science, Medicine and Rehabilitation, 2021;13:1-7. (SCIE, IF 2.367, Q2) - Co-corresponding author

Jeong M, Kim KJ, Lee W*. Consideration of Legal Implications of the Patent Dispute Judgement on Solifenacin Salt Chage. Yakhak Hoeji, 2021;65(1):56-63. (KCI) - Co-author 

Kim KJ, Choi CO, Kim DG, Song MS, Kim MH, Jung HC*, Lee GH*. Short-term Clinical Outcomes and Assessment of Diabetes Self-care Activities of the Community Pharmacy Diabetes Care Service in South Korea: A Pilot Study.  Korean Journal of Community Pharmacy, 2019:5(1):1-7. - First author

Kim KJ, Shin MJ, Moon KR*. Assessment of Risk of Refeeding Syndrome Caused by Early Nutrition in Low Body Weight Patients Referred to NST. Journal of Korean Society of Health-System Pharmacists, 2019;36(1):88-96. (KCI) - First author

Cho YH, Kim KJ*. The Evaluation of drug utilization review on potentially inappropriate medications for Elderly Patients in a Tertiary Hospital. Korean Journal of Clinical Pharmacy, 2019;29(1):25-32. (KCI) - Corresponding author

Han S, Kim KJ, Bang JS*. The awareness of contraception and experience of oral contraceptives among North Korean defector women in Republic of Korea. Korean Journal of Clinical Pharmacy, 2019;29(1):33-44. (KCI) - Co-author

Kim KJ*, Jang HY, Kang MK. Evaluation of the Clinical Effect of Intravenous Glutamine on Intensive Care Unit Patients. Annals of Clinical Nutrition and Metabolism. 2019;11(1):23-28. - First author

Kim KJ, Choe I, Kwon YE*. Clinical Aspects of Unpredictable Adverse Drug Reaction and Assessment of Drug Casuality. Journal of Korean Society of Health-System Pharmacists, 2018;35(3):331-339. (KCI) - First author

Na SJ, Kim JY, Kim KJ, Lee W*. Consideration of patent dispute over sibutramine related drugs. Yakhak Hoeji, 2017;61(6):335-343. (KCI) - Co-author

Kim JY, Kim KJ, Park SW, Bang JS, Lee W*. Investigation on adhesion control standards and skin adverse effects of skin attached formulations. Korean Journal of Clinical Pharmacy, 2014;24(3):219-228.  (KCI) - Co-author

Kim SH, Bang JS, Kim KJ, Lee YJ*. A Case of Neutripenia Induced by Short-Term Treatment of Vancomycin. Korean Journal of Clincial Pharmacy. 2013;23(1):77-80. (KCI) - Co-author